Answers are grounded in this paper and cite their sources.
Observational study shows Ion Cyclotron Resonance significantly reduces chronic pain in patients, suggesting new therapeutic techniques.
The rising field of quantum medicine defines matter, even in biological systems, as an element in constant electromagnetic resonance based on the interaction of ultra-weak electromagnetic fields1. The electromagnetic activity that characterizes each element, including biological tissues and individual cells, could play a fundamental role in the advancement of diagnostic and therapeutic techniques2. A therapeutic approach that falls into this field is Ion Cyclotron Resonance (ICR), which exploits targeted ultra-weak electromagnetic fields to restore impaired enzymatic activities in the body by moving ions and restoring molecular exchanges between cell membranes3. However, given the novelty of the approach, more studies are needed to assess the mechanisms of action and the actual efficacy of the treatment. Therefore, we conducted a pilot observational study involving 7 men and 7 women (average age 57.4±8.4 and 68.7±14.7 years respectively) to verify the efficacy and safety of a 6 sessions cycle of Ion Cyclotron Resonance therapy in reducing chronic musculoskeletal pain, detected by the Numeric Pain Rating Scale, and restoring a correct whole-body hydroelectrolytic balance monitored through the bioelectrical impedance analysis. The results of our study associate the ICR treatment with a significant improvement in all observed parameters between the beginning and the end of the treatment cycle. No treatment-related adverse effects were observed during the observation. Our study may lay the foundation for new and more in-depth research on the topic. New studies will require the cooperation of multiple disciplines, from physics to histochemistry through the various health specialties, in order to frame the biochemical and clinical effects of this therapeutic approach in a perspective of multidisciplinary collaboration and translational medicine4.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: